This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

John B. Graham, MD; Natalija Petersons, MD

JAMA. 1964;189(9):697-698.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SOME PATIENTS with advanced cancer tolerate skin homografts longer than normal.^1-2 This is regarded as evidence of an impaired defense mechanism. We thought that perhaps a significant correlation could be found between the skin homograft rejection time and the clinical course of patients with cancer. Accordingly, we routinely applied skin grafts to all patients with primary cervical cancer admitted to the gynecology service. A full-thickness ellipse of skin, 0.6 x 1.0 cm, from another patient was applied to the forearm and held in place with a pressure dressing. The first sign of blanching or cyanosis was regarded as the end of survival. Grafts that survived 15 days or more were classified as prolonged. The frequency of prolonged survival in various types of patients is indicated in Tables 1 and 2. There were 107 patients who received no cancer treatment before the graft was applied or while it was in . . . [Full Text PDF of this Article]

Author Affiliations
Buffalo

From the Department of Gynecology, Roswell Park Memorial Institute.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?